Warshaw, Erin M <br/><br/>
Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Aug 2007 
 - 257-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1097-6787 
<br/><br/><label>Standard No.: </label>10.1016/j.jaad.2006.11.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Dermatitis, Seborrheic--drug therapy<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Eruptions--etiology<br/>Facial Dermatoses--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Satisfaction<br/>Severity of Illness Index<br/>Tacrolimus--administration & dosage<br/>Treatment Outcome